Belpointe Asset Management LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$14,545
-86.8%
475
-83.2%
0.00%
-85.7%
Q4 2022$110,486
-19.4%
2,825
-1.7%
0.01%
-22.2%
Q3 2022$137,000
-0.7%
2,875
+19.8%
0.01%
+12.5%
Q1 2022$138,000
-28.9%
2,400
-1.4%
0.01%
-33.3%
Q4 2021$194,000
-8.5%
2,4350.0%0.01%
-14.3%
Q3 2021$212,000
-32.1%
2,435
+0.3%
0.01%
-36.4%
Q2 2021$312,000
+60.8%
2,4270.0%0.02%
+29.4%
Q1 2021$194,000
+0.5%
2,427
+2.9%
0.02%0.0%
Q4 2020$193,0002,3590.02%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders